Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from FOXO Technologies ( (FOXO) ) is now available.
On January 28, 2025, FOXO Technologies Inc. reported significant achievements in late 2024, including a comprehensive turnaround that improved shareholders’ equity by over $21 million through debt restructuring. The company plans to expand its healthcare services and monetize its epigenetics division in 2025, while seeking further acquisitions to enhance shareholder value.
More about FOXO Technologies
FOXO Technologies Inc. operates in the biotechnology and healthcare sectors, focusing on epigenetic biomarker discovery, behavioral health services, and rural hospital operations. The company aims to extend human life through prognostics and therapeutic solutions, while also managing healthcare facilities in East Tennessee.
YTD Price Performance: -8.62%
Average Trading Volume: 55,858,259
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.44M
Learn more about FOXO stock on TipRanks’ Stock Analysis page.
